Job burnout is at an all-time high, with about 66 percent of employees experiencing it, according to a FORBES study. RISEUP is a new career development tool designedJob burnout is at an all-time high, with about 66 percent of employees experiencing it, according to a FORBES study. RISEUP is a new career development tool designed

RISEUP, the new career growth tool helping you build what is next

Job burnout is at an all-time high, with about 66 percent of employees experiencing it, according to a FORBES study. RISEUP is a new career development tool designed to help you shape your future and explore career pivots with professional guidance. Here’s a closer look at the startup that aims to transform work culture for the better.

A global approach for effective solutions 

RISEUP supports professionals during key moments in their careers. It helps early-career individuals (0–5 years of experience) establish a solid foundation, find their voice, and build confidence to stand out. Mid-career professionals (6–15 years) who feel stuck, burned out, or want to shift toward more meaningful work can also benefit. Returning professionals re-entering the workforce after a break and looking to tell their story confidently and redefine success on their own terms are supported as well. Unlike traditional career programs that mainly focus on landing a job, RISEUP emphasizes growth beyond offers. While many programs focus on interview prep, generic skills, or pre-recorded courses, RISEUP centers on strategic career planning and sustainable workplace development. It combines live webcasts, one-on-one coaching, role-specific tools, simulations, and guided prompts to foster growth in real workplace situations. This approach goes beyond simple job-search tips, offering a comprehensive vision board with practical tools to reinvent your professional story.

RISEUP, the new career growth tool helping you build what is next

Redefining what growth means

In today’s world, success is versatile. An employee can be happy with their position, yet want to redefine what is important to them once they start a family. They may need guidance on redefining their responsibilities and communicating their new vision to their employers. Career guidance is not a cookie-cutter art; it is not a one-size-fits-all solution. RISEUP offers personalized solutions. RISEUP helps professionals define growth based on their current values, goals, and energy, not external expectations. The company guides participants to rebuild their resumes and personal brands with clarity and intention, practice high-stakes conversations and interviews in a safe environment, and grow their careers in alignment with both ambition and well-being.

Unique tools rooted in storytelling and unique media practices

RISEUP was established by Dr. Deepak Bhootra, a sales coach, investor, and experienced business leader who helps sales professionals and entrepreneurs win more while reducing stress. With over 30 years of global experience across four countries, he combines psychology, strategy, and practical execution to enhance sales performance. As the founder and CEO of Jabulani Consulting and a GTM & Sales Advisor for SAt SalesTable, Deepak works closely with teams and leaders to develop a strong sales mindset, close larger deals, and build predictable, sustainable revenue streams. He emphasizes that success through transformative decisions needs tailored support and guidance. RISEUP offers this crucial support through personalized one-on-one mentoring.

In an exciting update, RISEUP has teamed up with NYC-based actor Vaibhav Taparia, renowned for his versatile work in stage and film. He not only appears in the coaching videos but also lends his skills to the coaching components of the program.

Your compass for every big professional decision

RISEUP is more than just a career program; it’s a guiding light during critical moments in our professional lives. Amidst chaos, pressure, and conflicting expectations, RISEUP empowers young professionals worldwide to pause, gain clarity, and make intentional choices. It offers a powerful framework for evaluating opportunities, navigating difficult trade-offs, and pursuing careers that truly reflect their core values, vitality, and long-term vision—rather than succumbing to fear or external validation. Whether choosing to say yes, saying no, or redefining success, RISEUP inspires confidence and purpose, helping emerging leaders around the globe step forward with clarity and boldness.

https://www.riseupcareerstudio.com/

Comments
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

$5,000 Invested in Ripple (XRP) 10 Years Ago Is Worth Millions Today, But This Coin Will do it in a Year

$5,000 Invested in Ripple (XRP) 10 Years Ago Is Worth Millions Today, But This Coin Will do it in a Year

Ripple (XRP) has demonstrated the enormous growth ability of cryptocurrencies, as a 10-year-old investment of $5,000 now costs millions.
Share
The Cryptonomist2025/09/19 20:09
OFAC Designates Two Iranian Finance Facilitators For Crypto Shadow Banking

OFAC Designates Two Iranian Finance Facilitators For Crypto Shadow Banking

The Department of the Treasury’s Office of Foreign Assets Control (OFAC) sanctioned two Iranian financial facilitators for coordinating over $100 million worth of cryptocurrency in oil sales for the Iranian government, a September 16 press release shows. OFAC Sanctions Iranian Nationals According to the Tuesday press release, Iranian nationals Alireza Derakhshan and Arash Estaki Alivand “used a network of front companies in multiple foreign jurisdictions” to transfer the digital assets. OFAC alleges that Alivand and Derakhshan’s transfers also involved the sale of Iranian oil that benefited Iran’s Islamic Revolutionary Guard Corps-Qods Force (IRGC-QF) and the Ministry of Defense and Armed Forces Logistics (MODAFL). IRGC-QF and MODAFL then used the proceeds to support regional proxy terrorist organizations and strengthen their advanced weapons systems, including ballistic missiles. U.S. officials say the move targets shadow banking in the region, where illicit financial actors use overseas money laundering and digital assets to evade sanctions. “Iranian entities rely on shadow banking networks to evade sanctions and move millions through the international financial system,” said Under Secretary of the Treasury for Terrorism and Financial Intelligence John K. Hurley. “Under President Trump’s leadership, we will continue to disrupt these key financial streams that fund Iran’s weapons programs and malign activities in the Middle East and beyond,” he continued. Dozens Designated In Shadow Banking Scandal Both Alivand and Derakhshan have been designated “for having materially assisted, sponsored, or provided financial, material, or technological support for, or goods or services to or in support of the IRGC-QF.” In addition to Alivand and Derakhshan, OFAC has sanctioned more than a dozen Hong Kong and United Arab Emirates-based entities and individuals tied to the network. According to the press release, the sanctioned entities may face civil or criminal penalties imposed as a result
Share
CryptoNews2025/09/18 11:18
TuHURA Biosciences received FDA Orphan Drug Designation for IFx-2.0 for the Treatment of Stage IIB to Stage IV Cutaneous Melanoma

TuHURA Biosciences received FDA Orphan Drug Designation for IFx-2.0 for the Treatment of Stage IIB to Stage IV Cutaneous Melanoma

TAMPA, Fla., Feb. 2, 2026 /PRNewswire/ — TuHURA Biosciences, Inc. (NASDAQ:HURA) (“TuHURA” or the “Company”), a Phase 3 immuno-oncology company developing novel
Share
AI Journal2026/02/02 21:15